Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 48

1.

An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA).

Chenevix-Trench G, Milne RL, Antoniou AC, Couch FJ, Easton DF, Goldgar DE; CIMBA.

Breast Cancer Res. 2007;9(2):104.

PMID:
17466083
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers.

Jakubowska A, Gronwald J, Menkiszak J, Górski B, Huzarski T, Byrski T, Edler L, Lubiñski J, Scott RJ, Hamann U.

Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):270-5.

PMID:
17301259
[PubMed - indexed for MEDLINE]
Free Article
3.

Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review.

Bonadona V, Dussart-Moser S, Voirin N, Sinilnikova OM, Mignotte H, Mathevet P, Brémond A, Treilleux I, Martin A, Romestaing P, Raudrant D, Rudigoz RC, Lenoir GM, Lasset C.

Breast Cancer Res Treat. 2007 Jan;101(2):233-45. Epub 2006 Oct 24.

PMID:
17061047
[PubMed - indexed for MEDLINE]
4.

The 185delAG mutation (c.68_69delAG) in the BRCA1 gene triggers translation reinitiation at a downstream AUG codon.

Buisson M, Anczuków O, Zetoune AB, Ware MD, Mazoyer S.

Hum Mutat. 2006 Oct;27(10):1024-9.

PMID:
16941470
[PubMed - indexed for MEDLINE]
5.

A region of human BRCA2 containing multiple BRC repeats promotes RAD51-mediated strand exchange.

Shivji MK, Davies OR, Savill JM, Bates DL, Pellegrini L, Venkitaraman AR.

Nucleic Acids Res. 2006;34(14):4000-11. Epub 2006 Aug 16.

PMID:
16914443
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).

Andrieu N, Goldgar DE, Easton DF, Rookus M, Brohet R, Antoniou AC, Peock S, Evans G, Eccles D, Douglas F, Noguès C, Gauthier-Villars M, Chompret A, Van Leeuwen FE, Kluijt I, Benitez J, Arver B, Olah E, Chang-Claude J; EMBRACE; GENEPSO; GEO-HEBON; IBCCS Collaborators Group.

J Natl Cancer Inst. 2006 Apr 19;98(8):535-44.

PMID:
16622123
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population.

Simchoni S, Friedman E, Kaufman B, Gershoni-Baruch R, Orr-Urtreger A, Kedar-Barnes I, Shiri-Sverdlov R, Dagan E, Tsabari S, Shohat M, Catane R, King MC, Lahad A, Levy-Lahad E.

Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3770-4. Epub 2006 Feb 28.

PMID:
16537453
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance.

Chenevix-Trench G, Healey S, Lakhani S, Waring P, Cummings M, Brinkworth R, Deffenbaugh AM, Burbidge LA, Pruss D, Judkins T, Scholl T, Bekessy A, Marsh A, Lovelock P, Wong M, Tesoriero A, Renard H, Southey M, Hopper JL, Yannoukakos K, Brown M, Easton D, Tavtigian SV, Goldgar D, Spurdle AB; kConFab Investigators.

Cancer Res. 2006 Feb 15;66(4):2019-27.

PMID:
16489001
[PubMed - indexed for MEDLINE]
Free Article
9.

Regulation of gene expression by alternative untranslated regions.

Hughes TA.

Trends Genet. 2006 Mar;22(3):119-22. Epub 2006 Jan 23. Review.

PMID:
16430990
[PubMed - indexed for MEDLINE]
10.

Characterisation of the promoter region of the human DNA-repair gene Rad51.

Hasselbach L, Haase S, Fischer D, Kolberg HC, Stürzbecher HW.

Eur J Gynaecol Oncol. 2005;26(6):589-98. Review.

PMID:
16398215
[PubMed - indexed for MEDLINE]
11.

Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers.

Kramer JL, Velazquez IA, Chen BE, Rosenberg PS, Struewing JP, Greene MH.

J Clin Oncol. 2005 Dec 1;23(34):8629-35.

PMID:
16314625
[PubMed - indexed for MEDLINE]
Free Article
12.

Does nonsense-mediated mRNA decay explain the ovarian cancer cluster region of the BRCA2 gene?

Ware MD, DeSilva D, Sinilnikova OM, Stoppa-Lyonnet D, Tavtigian SV, Mazoyer S.

Oncogene. 2006 Jan 12;25(2):323-8.

PMID:
16170354
[PubMed - indexed for MEDLINE]
13.

A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes.

Antoniou AC, Goldgar DE, Andrieu N, Chang-Claude J, Brohet R, Rookus MA, Easton DF.

Genet Epidemiol. 2005 Jul;29(1):1-11.

PMID:
15880399
[PubMed - indexed for MEDLINE]
14.

Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer.

Webb PM, Hopper JL, Newman B, Chen X, Kelemen L, Giles GG, Southey MC, Chenevix-Trench G, Spurdle AB.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):319-23.

PMID:
15734952
[PubMed - indexed for MEDLINE]
Free Article
15.

Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction.

Luu-The V, Paquet N, Calvo E, Cumps J.

Biotechniques. 2005 Feb;38(2):287-93.

PMID:
15727135
[PubMed - indexed for MEDLINE]
Free Article
16.

A conserved Mis12 centromere complex is linked to heterochromatic HP1 and outer kinetochore protein Zwint-1.

Obuse C, Iwasaki O, Kiyomitsu T, Goshima G, Toyoda Y, Yanagida M.

Nat Cell Biol. 2004 Nov;6(11):1135-41. Epub 2004 Oct 24.

PMID:
15502821
[PubMed - indexed for MEDLINE]
17.

The BOADICEA model of genetic susceptibility to breast and ovarian cancer.

Antoniou AC, Pharoah PP, Smith P, Easton DF.

Br J Cancer. 2004 Oct 18;91(8):1580-90.

PMID:
15381934
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2.

Goldgar DE, Easton DF, Deffenbaugh AM, Monteiro AN, Tavtigian SV, Couch FJ; Breast Cancer Information Core (BIC) Steering Committee.

Am J Hum Genet. 2004 Oct;75(4):535-44. Epub 2004 Aug 2.

PMID:
15290653
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Emerging functions of BRCA2 in DNA recombination.

Pellegrini L, Venkitaraman A.

Trends Biochem Sci. 2004 Jun;29(6):310-6. Review.

PMID:
15276185
[PubMed - indexed for MEDLINE]
20.

The Icelandic founder mutation BRCA2 999del5: analysis of expression.

Mikaelsdottir EK, Valgeirsdottir S, Eyfjord JE, Rafnar T.

Breast Cancer Res. 2004;6(4):R284-90. Epub 2004 Apr 7.

PMID:
15217494
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk